source
- FDA approves all-oral decitabine/cedazuridine plus venetoclax for older or unfit AML patientsThe FDA has granted approval for the combination of decitabine and cedazuridine (Inqovi) with venetoclax (Venclexta) to treat newly diagnosed acute myeloid leukemia in adults who are at least 75 ye…
- FDA approves brexu-cel for adult relapsed/refractory mantle cell lymphomaThe U.S. Food and Drug Administration has granted approval for brexu-cel as a treatment option for adult patients with relapsed or refractory mantle cell lymphoma. Dr. Luhua (Michael) Wang discuss…